Mohamed E. Labib, pHD

Head of Novaflux and Protegera.

Mohamed Labib holds a PhD in physical chemistry from McGill University and is highly experienced in the development of medical devices, pharmaceuticals, biomaterials, and drug delivery. Dr. Labib founded NovaFlux, Inc. in 1988, and since then, he has managed multiple research and development programs at various institutions, including SRI International, NJIT, NovaFlux Inc., NovaFlux Biosciences, and Advanced BioDevices. Dr. Labib has also experienced significant achievements in the engineering field as a co-inventor of the micro-structured fluids (MSF) technology and its applications in the health-care field. In total, he has received more than 40 million dollars in research funding, published more than 40 papers, and holds over 50 patents.